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Abstract Many significant advances in our understand-
ing of intestine development, intestinal stem cell homeo-
stasis and differentiation have been made in recent years.
These advances include novel techniques to culture pri-
mary human and mouse intestinal epithelium in three-
dimensional matrices, and de novo generation of human
intestinal tissue from embryonic and induced pluripotent
stem cells. This short review will focus on the directed
differentiation of human pluripotent stem cells into intes-
tinal tissue, highlight novel uses of this tissue, and compare
and contrast this system to primary intestinal epithelial
cultures.
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Introduction
Undifferentiated stem cells, which drive embryogenesis
and development, are often responsible for adult tissue
maintenance and regeneration in response to injury [1].
Stem cells are defined by their long-term ability to divide
and self-renew and their ability to give rise to specialized
cell types through differentiation. Stem cells are classified
by the range of their potential to differentiate into spe-
cialized cells. For example, pluripotent stem cells are able
to give rise to any embryonic cell type whereas multipotent
stem cells can give rise to smaller subsets of more closely
related cell types. Adult stem cells are specialized to spe-
cific tissues and are often multipotent. They are responsible
for tissue homeostasis and regeneration after damage.
While they are capable of self-renewal and differentiation,
their ‘‘stemness’’ is reduced over time when grown in vitro
[1–4]. Unlike adult stem cells, pluripotent and embryonic
stem cells can give rise to all tissues found in the human
body and are virtually unlimited in their ability to prolif-
erate in vitro, making them attractive for use in biomedical
research and regenerative medicine.
Human pluripotent stem cells (hPSCs) broadly refer to
all pluripotent human stem cell types, including human
embryonic stem cells (hESCs) and induced pluripotent
stem cells (iPSCs). hESCs are most efficiently derived
from the inner cell mass of human blastocytes generated
during in vitro fertilization procedures [5]. They are com-
monly grown in culture on either inactivated feeder layers
of murine embryonic fibroblasts or under feeder-free con-
ditions on tissue culture plates coated with a basement
membrane protein substrate [5–7]. The development of
conditions for feeder-free derivation and growth of hESCs
[6, 8–11] has enabled standardized production of cells
more amenable for use in therapeutic applications
(reviewed elsewhere [12]).
One major challenge when using hESC-derived cells for
therapeutic purposes is generating tissue for transplantation
that will not be rejected by the patient’s immune system.
Another challenge for the use of hESCs has been the eth-
ical opposition to destroying human embryos during hESC
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isolation and accordingly, strict rules exist regarding deri-
vation and use of new hESC lines in projects reliant on US
federal funding. Recently, methods to reprogram human or
mouse ‘‘adult-like’’ somatic cells into ‘‘embryonic-like’’
stem cells was described by Shinya Yamanaka, a seminal
discovery awarded the Nobel Prize in Medicine in 2012
[13, 14]. This method, called cellular reprogramming, was
used to generate mouse and human iPSCs from fibroblast
cells through the forced expression of a specific set of
transcription factors (Oct4, Sox2, Klf4, c-Myc) [15–18].
These reprogrammed cells resemble hESCs in morphology
and stem cell-defining characteristics, although detailed
comparative gene expression studies suggest that there may
be important differences between hESCs and iPSCs
(reviewed elsewhere [19]). The original protocol for iPSC
generation involved use of retroviral vectors which leave a
‘‘genetic footprint’’ in the reprogrammed cell, raising
concerns for the safety of using iPSCs for transplantation
[16]. In recent years, the methods have been further refined
to eliminate the use of retroviruses [18], thus making it
possible to generate patient-specific iPSCs without chang-
ing the genetic composition of the cells.
hPSCs, embryonic and induced, can now be used to
study and recapitulate many embryonic developmental
stages in vitro. Translational embryology is an emerging
field in which researchers are able to use what we know
about different stages of embryonic development to direct
differentiation of pluripotent stem cells into specialized
cells and tissues (reviewed elsewhere [20, 21]). Directed
differentiation is achieved by treating cells with recombi-
nant proteins or small molecules that regulate important
developmental signaling pathways, thereby mimicking key
events during in vivo development. This approach has been
used to generate a wide spectrum of cell types derived from
all three primary germ layers (ectoderm, mesoderm, and
endoderm), holding great promise for studies and treat-
ments of many diseases [21, 22]. This review focuses on
recent advances that used directed differentiation to gen-
erate intestinal tissue from hPSCs.
Growing the Intestine In Vivo
Differentiation of hESCs or iPSCs into intestinal tissue
requires a step-wise process mimicking major develop-
mental events including definitive endoderm differentia-
tion, gut specification and morphogenesis, and intestine
development, growth, and homeostasis. We will briefly
highlight these major developmental milestones. The three
primary germ layers, generated in the process of gastrula-
tion during embryogenesis, all contribute to the develop-
ment of the intestine. The enteric nervous system that
innervates the gut arises from the ectoderm; the smooth
muscle, connective tissue, and vasculature of the gut arise
from the mesoderm; and intestinal epithelium arises from
the endoderm [23–26]. For the purpose of this review, we
will focus on the development of the intestinal epithelium.
The TGF-b superfamily member Nodal is essential for
the specification of endoderm. Variable levels of exposure
to this growth factor control anterior–posterior (A–P) pat-
terning of the endoderm [27]. Fibroblast growth factor
(FGF), Wnt, bone morphogenetic protein (BMP), and ret-
inoic acid signaling are also involved in A–P patterning
and induction of tissue-specific transcription factors
(reviewed elsewhere [23, 28]). Simultaneous with forma-
tion of the gut tube, the endoderm is specified into future
intestinal epithelium primarily through the induction of the
transcription factor Cdx2 [29–32]. At this stage, the
intestine is a single layer of Cdx2? cuboidal epithelial
cells that transitions to become a pseudostratified epithe-
lium. The subsequent rapid expansion and thickening of the
pseudostratified epithelium is responsible for increasing the
length and girth of the intestine [33, 34]. Substantial
remodeling then takes place, forming a single layer of
columnar epithelium. The formation of the columnar epi-
thelium is coincident with the emergence of villi and
highly proliferative intervillus regions [35–37]. The
mechanistic details of villus morphogenesis and formation
of the intervillus regions is not entirely known; neverthe-
less, evidence suggests crosstalk between the epithelium
and mesenchyme through the Hedgehog, BMP, platelet-
derived growth factor (PDGF), transforming growth factor
(TGF)-b, and Wnt pathways are important for the process
(reviewed elsewhere [24, 38]). Transcription factors such
as Gata4 and Gata6 are later involved in the specification of
proximal versus distal intestine [39–41], although other
less well understood factors are also likely involved.
After villus morphogenesis is complete, epithelial pro-
liferation becomes restricted to the intervillus regions of
the embryonic intestine. It is generally speculated that the
cells in the intervillus region may give rise to the adult
stem cells residing in the crypts of Lieberku¨hn, however,
this has not been formally demonstrated. Notably, many of
the best characterized adult intestinal stem cell (ISC)
markers are not expressed in the proliferative embryonic
intervillus domain [42, 43], suggesting that proliferating
embryonic progenitor cells and adult stem cells in the crypt
are not molecularly equivalent. Five differentiated cell
types appear during and after emergence of villi: entero-
cytes (or colonocytes in the large intestine), goblet, tuft,
enteroendocrine, and M-cells [44, 45]. In the mouse, Pa-
neth cells appear in the small intestine only after crypts
develop postnatally [42].
Once the crypts emerge during intestinal maturation,
Wnt/b-catenin and Notch signaling are two critical path-
ways involved in the regulation of intestinal proliferation
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and cytodifferentiation (reviewed elsewhere [46]). Since
many molecular markers of ISC are Wnt target genes, it is
likely that Wnt signaling is essential for ISC maintenance
[47]. Wnt signaling also controls Paneth cell differentia-
tion, consistent with the spatial co-localization of ISCs and
Paneth cells at the base of the crypts where Wnt signals are
high [48]. The Notch pathway is critical for ISC self-
renewal and differentiation [49–51] (reviewed in [52]).
During differentiation, Notch/Hes1 signaling in absorptive
cells opposes expression of the secretory transcription
factor Atoh1/Math1 [50, 53, 54]. Further specification of
secretory cell types occurs downstream of Atoh1/Math1
through Neurogenin3 [55, 56] for enteroendocrine cells,
Gfi1, and SPDEF [57–59] for goblet cells, and Gfi1, Sox9,
and SPDEF for Paneth cells [58–62]. Crosstalk between the
Wnt/b-catenin and Notch signaling pathways needs to be
further elucidated given reports of Wnt also playing a role
in cell fate decisions [63–66].
Growing Intestinal Tissue In Vitro
Primary Intestinal Epithelial Culture Methods
and Nomenclature
Major breakthroughs in our understanding of ISC regula-
tion have been made over the last few years [36, 49, 67–
71]. These advances have, in turn, had several positive
consequences including the identification of novel ISC
markers, an explosion in the development of new genetic
tools to identify and study ISCs in mice [72–76], opening
new avenues to develop therapeutic drugs to treat intestinal
cancer [77], and technological breakthroughs enabling
researchers to grow robust primary epithelial cultures from
mouse and human intestine [78–80]. To date, many groups
have published methodologies for growing primary intes-
tinal epithelial cultures [78–83], which all include the core
tenets that three-dimensional (3D) structure and high levels
of Wnt signaling are critical to maintain long-term growth
in vitro. Due to their robustness, development of these 3D
culture methods have yielded powerful, physiologically
relevant systems that facilitate the study of intestinal
homeostasis [48, 51], gene regulation and function [48, 84,
85], and have additional promise for the performance of
biochemical assays and drug screens. High Wnt signaling
and 3D intestinal culture conditions [78, 79] enabled the
expansion of human embryonic gut-like tissue derived
from hPSCs into more mature human intestinal ‘‘orga-
noids’’ [31, 86] (see ‘‘Generating Induced Human Intestinal
Organoids (iHIOs)’’ section).
Given the diverse methods and tissue sources for pri-
mary intestinal cultures, there has been a recent initiative
for the gastrointestinal research community to adopt a
common nomenclature [87] (Table 1), although to date, a
consensus has not been reached. This may be due, in part,
to the fact that one of the original papers describing
intestinal epithelial culture conditions referred to the
resulting 3D structures as ‘‘intestinal organoids’’ [78].
These ‘‘organoids,’’ described by Sato et al. [78] are epi-
thelial in nature, and contain no mesenchyme. Further,
these epithelial-only cultures have been published and
referred to as organoids in more than 30 publications since
2009. Stelzner et al. [87] proposed that these epithelial
cultures be re-coined ‘‘enteroids,’’ since they are solely
derived from the enteric epithelium and that the term
‘‘organoid’’ be reserved for tissue that more closely
resembles the organ proper, composed of multiple tissue
types including the epithelial and mesenchymal compo-
nents characteristic of native intestine. Stelzner et al. also
suggest referring to in vitro generation of intestinal tissue
from non-intestinal sources as ‘‘induced’’ intestine. For the
purposes of this review, we will refer to intestine derived
from human embryonic or iPSCs as ‘‘induced human
intestinal organoids’’ (iHIOs). As the suggested system for
nomenclature implies, iHIOs contain epithelial and mes-
enchymal tissue. We caution readers not to confuse iHIOs
Table 1 Description of terms and abbreviations
Abbreviations Full name Description
hESC Human embryonic stem cell Pluripotent cells derived from human embryo
iPSC Induced pluripotent stem cells Pluripotent cells derived from reprogrammed somatic cells
Spheroid Intestinal spheroid or mid/hindgut spheroid 3D structure generated from human endoderm, resembling early
embryonic gut tissue. Spheroids expand and give rise to iHIOs
Organoid Organoid 3D organ-like structure grown in vitro that resembles a complex
organ in blank;vivo, including multiple cell and tissue types
iHIO Induced human intestinal organoid 3D intestinal tissue generated from pluripotent stem cells, comprised
of intestinal epithelial and mesenchymal tissue
Enteroid Enteroid Primary intestinal epithelium grown in culture, can be generated from
mouse or human intestinal epithelium
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with epithelial-only cultures derived from isolated intesti-
nal epithelium, crypts or single ISCs (Table 1).
Generating Induced Human Intestinal Organoids
(iHIOs)
As already highlighted, human embryonic and iPSCs have
been highly touted for their potential to treat or cure dis-
ease through cell-based transplantation therapies. Never-
theless, the potential for hPSCs goes far beyond that of
transplantation. hPSCs also hold amazing potential to
accurately mimic human development, homeostasis, and
disease in vitro. Work over the past decade has focused on
understanding regulation of pluripotency and differentia-
tion in hPSCs. More recently, directed differentiation has
emerged as the most efficient approach to achieving
in vitro generation of a cell or tissue of interest [48, 82, 83,
88–102]. Many breakthroughs in pluripotent stem cell
differentiation have occurred using two-dimensional (2D)
culture conditions directed at generating a single cell
type of interest. In contrast, generation of 3D organ units
(organoids) or more complex tissue from hPSCs has only
recently been recognized as a viable approach for differ-
entiation [31, 103, 104]. Such 3D models will offer com-
plex multi-lineage, multi-cellular systems that can more
closely recapitulate both normal physiology as well as
pathological conditions in vitro, forming the basis for new
in vitro human models designed to help understand normal
homeostasis, complex multigenic diseases, perform drug
screens, and validate the efficacy of new drugs prior to
clinical trials [105].
Using directed differentiation, we were able to suc-
cessfully generate 3D intestinal tissue by recapitulating
embryonic development of the intestine in vitro [31, 86].
We employed a step-wise differentiation protocol that
included endoderm induction, A–P patterning, intestinal
lineage commitment, and intestinal growth and differenti-
ation (Fig. 1). In the embryo, as cells migrate through the
primitive streak, they are exposed to Nodal, a TGFß family
member. Depending on the concentration and time of
exposure to Nodal signaling, cells adopt either a meso-
dermal or endodermal fate en route to forming their proper
germ layer [106–117]. In hPSCs, robust and efficient
endoderm induction is achieved by mimicking Nodal sig-
naling using Activin A [20, 88, 118]. We are routinely able
to generate human endoderm cultures with [85 % effi-
ciency, determined by co-staining of the transcription
factors SOX17 and FOXA2 using a well-established 3-day
differentiation protocol [31, 88]. Following induction, we
consider the resulting human FOXA2?/SOX17? endo-
dermal tissue to be naive, capable of giving rise to all
endodermal lineages including pancreatic (PDX1?),
hepatic (ALB?), biliary (SOX17?), and intestinal
(CDX2?) [31, 119].
During endoderm induction, the embryo simultaneously
undergoes complex morphogenetic movements and pat-
terning events to give rise to the early gut tube, which is
patterned into different domains along the A–P and dorsal–
ventral (D–V) axes with the different domains giving rise
to different subsets of endodermal organs [23, 109, 120–
124]. Of note, work done in a host of vertebrate organisms
has shown that an increasing anterior-to-posterior gradient
of FGF, WNT and BMP signaling acts to posteriorize the
endoderm [28, 125–129]; WNT and/or FGF signaling is
able to induce human endoderm towards CDX2? intestinal
lineages [31, 32]. In FGF4 ? WNT3A treated induced
human endoderm, we observed robust and stable induction
of CDX2 in *95 % of cells after 96 h of treatment.
Remarkably, we also observed dramatic morphogenetic
movements in the tissue culture dish, which gave rise to
gut-like ‘‘spheroids,’’ which were small 3D clusters of cells
that budded from the underlying monolayer. These spher-
oids were comprised of an inner epithelial layer and outer
mesenchymal layer. Although the mechanisms downstream
of FGF and/or WNT signaling that govern these complex
in vitro morphogenetic tissue movements are unclear, this
Fig. 1 Schematic of human pluripotent stem cell-derived intestinal
organoids. Human-induced pluripotent (iPSC) or embryonic (hESC)
stem cells are differentiated into FOXA2/SOX17 positive endoderm
with [85 % efficiency. A small proportion of cells (*2–5 %) also
differentiate into Brachyury (T)-positive mesoderm. Induction of the
intestinal epithelial transcription factor CDX2 is achieved by
activating FGF and WNT signaling for 4 days. The mesenchymal
population expands and expresses the intestine–mesenchyme
transcription factor FOXF1. During this 4-day induction, 3D spher-
oids comprised of CDX2? epithelial and FOXF1? mesenchymal
layers form, and delaminate from the tissue culture dish. Spheroids
are then cultured in a 3D matrix (Matrigel) in ‘‘high WNT’’
conditions (WNT3A and/or RSPO1) along with EGF and Noggin
(NOG). During the first month in culture, spheroids expand drastically
in size, giving rise to iHIOs. iHIOs can be split and re-cultured, and
maintained for many months in vitro
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system will likely be an excellent tool to study how com-
plex tissue movements and tube formation occurs.
Following spheroid formation, we took advantage of
pro-intestinal conditions established by Sato et al. [78] and
continued to culture spheroids embedded in Matrigel and
medium supplemented with recombinant human growth
factors that promoted high levels of WNT signaling
(WNT3A and/or RSPO1). Spheroid size and complexity
increased remarkably over 1 month, giving rise to an epi-
thelial and mesenchymal layer. The epithelium expressed
molecular markers typical of many small intestinal cell
types, including enteroendocrine cells (chromogranin A),
goblet cells (mucin2), Paneth cells (lysozyme), and en-
terocytes (dipeptidyl peptidase (DPP)4, villin). We also
observed that when iHIOs were cultured for [2 months,
expression of ISC markers such as achaete-scute complex
homolog 2 (ASCL2) and leucine-rich repeat-containing
G-protein coupled receptor 5 (LGR5) were observed.
Using iHIOs, we have published a limited number of
experiments to show that the epithelium appears to be
functional and behaves in a normal physiological manner.
For example, the epithelium in iHIOs is turned over every
6–7 days, similar to intestinal cell turnover in vivo [84,
130–132]. We have also demonstrated that iHIOs have a
functional enterocyte peptide transport system by visual-
izing transport of a fluorescently labeled dipeptide [31,
133].
Experimental Utility of iHIOs and Enteroids
Epithelial-only enteroids generated from adult mouse or
human intestinal epithelium have a proven track record as a
highly useful tool for studying physiologically relevant
events, such as ISC regulation and differentiation. In this
light, it is important to highlight some of the advantages
that iHIOs have to offer, as well as to point out potential
disadvantages compared to enteroid cultures. One of the
most significant advantages iHIOs offer is the ability to use
this model to study human embryonic events in vitro. We
have demonstrated that, much like the developing intestine
in vivo, iHIOs transition from an early hindgut-like stage
into a pseudostratified epithelium, which then undergoes
tissue rearrangements that give rise to a columnar epithe-
lium that has villus-like structures and proliferating
intervillus-like domains [31, 38]. Further, development and
differentiation of specialized cell types in the normal
intestine are reflected in iHIOs. For example, we demon-
strated that knockdown or overexpression of Neurog3 led
to a respective decrease or increase of enteroendocrine
cells in iHIOs, consistent with the described role of Neu-
rog3 in humans and mice [31, 55, 134–136]. Recently, it
has also been demonstrated that the transcription factor Arx
is also critical for proper enteroendocrine development in
the developing mouse intestine and in iHIOs [137].
A second advantage of iHIOs is their multi-lineage
composition. That is, iHIOs have an endodermally derived
epithelial layer, and a mesodermally derived mesenchymal
layer. The presence of both germ layers is a byproduct of
the ActivinA endoderm differentiation protocol used in the
first step in iHIO generation. While differentiation is very
efficient, and routinely generates *90 % endoderm, a
small population of cells differentiate into Brachyury (T)-
positive mesodermal progenitors that give rise to FoxF1?
intestinal mesenchymal progenitors. The iHIO mesenchy-
mal layer, while disorganized, is comprised of multiple cell
types, including smooth muscle (smooth muscle actin ?),
intestinal subepithelial myofibroblasts (ISEMF), and
fibroblasts [31]. Since iHIOs possess this mesenchymal
layer, they can be used to study intestinal mesenchymal
biology in addition to epithelial-mesenchymal interactions.
A third advantage of iHIOs is the ability to generate
patient-specific intestinal tissue for the study of human
disease. With the recent advances in generating induced
pluripotent stem cell lines [15, 16], it is now possible to
generate intestinal tissue from patients with specific dis-
eases. Although likely possible, it is currently unclear
whether enteroids (epithelium only) can be generated from
diseased or damaged epithelium.
Coupling these two in vitro systems (iHIOs and enter-
oids) to study intestinal disease will be ideal given their
distinct advantages. For example, iHIOs will enable the
study of ‘‘healthy’’ intestinal tissue from an individual
whereas enteroids from the same individual will have been
exposed to the disease environment in vivo. For example,
iHIOs generated from individuals with inflammatory bowel
disease (IBD) will have ‘‘healthy,’’ non-inflamed intestinal
tissue, with no exposure to the immune system whereas
enteroids from the same patient will have had exposure to
inflammation and the immune system. Therefore, intestinal
tissue that has been in a disease-state (enteroids) and a non-
disease state (iHIOs) from this patient can be examined,
compared and experimentally manipulated. In this light,
iHIOs will be a very powerful tool to elucidate the path-
ogenesis of complex multigenic human diseases.
Perspectives
Emerging evidence suggests that iHIOs will be useful for a
wide variety of studies, such as infectious diseases [138].
As iHIOs are more widely adopted as a model to study
human intestinal biology and pathobiology, their true
utility and limitations will become more apparent. The
significance of having complex, multi-lineage (mesen-
chyme, epithelium) 3D human intestinal tissue as a model
1180 Dig Dis Sci (2013) 58:1176–1184
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experimental system will likely be unparalleled. In this
light, it will be exciting to see how the scientific commu-
nity puts this novel system to use.
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